UK markets closed

10x Genomics, Inc. (0A88.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
27.69+0.87 (+3.24%)
At close: 07:06PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.89
52-week change 3-23.37%
S&P500 52-week change 322.36%
52-week high 363.24
52-week low 327.02
50-day moving average 345.52
200-day moving average 348.11

Share statistics

Avg vol (3-month) 3574
Avg vol (10-day) 3720
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 8103.27M
% held by insiders 12.38%
% held by institutions 195.73%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -41.23%
Operating margin (ttm)-15.76%

Management effectiveness

Return on assets (ttm)-12.22%
Return on equity (ttm)-32.98%

Income statement

Revenue (ttm)618.73M
Revenue per share (ttm)5.28
Quarterly revenue growth (yoy)17.80%
Gross profit (ttm)N/A
EBITDA -159.44M
Net income avi to common (ttm)-255.1M
Diluted EPS (ttm)-0.80
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)388.7M
Total cash per share (mrq)3.26
Total debt (mrq)95.37M
Total debt/equity (mrq)12.87%
Current ratio (mrq)4.69
Book value per share (mrq)6.22

Cash flow statement

Operating cash flow (ttm)-15.2M
Levered free cash flow (ttm)30.63M